Three-month Prostate-specific Antigen Level After Androgen Deprivation Therapy Predicts Survival in Patients With Metastatic Castration-sensitive Prostate Cancer

Background/Aim: Although upfront combination therapies with androgen deprivation are recommended for patients with castration-sensitive prostate cancer (CSPC), combination therapies may be excessive for some patients. The aim of this study was to identify patients with favorable outcome under androg...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:In Vivo
Main Authors: FUJIMOTO, NAOHIRO, SHIOTA, MASAKI, MATSUKAWA, TAKUO, MINATO, AKINORI, TOMISAKI, IKKO, OHNISHI, REI, ETO, MASATOSHI
Format: Artigo
Sprog:Inglês
Udgivet: International Institute of Anticancer Research 2021
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8045089/
https://ncbi.nlm.nih.gov/pubmed/33622907
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12355
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker